Bottom line
SHSCX vs QAAGZX: the short answer
SHSCX (Blackrock Health Sciences Opportunities Portfolio) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.
QAAGZX is cheaper at 0.86% vs 1.9% — a difference of $104 a year per $10,000 invested.
Over five years, SHSCX returned +4.8% a year vs +4.1% for QAAGZX.
Updated Nov 19, 2026
SHSCX vs QAAGZX side by side
| SHSCX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | BlackRock | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.9% | 0.86% |
| Annual cost per $10k | $190 | $86 |
| 10-yr cost on $10k (prospectus) | $2,016 | $1,061 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +14.1% | +18.1% |
| 5-yr return (annualized) | +4.8% | +4.1% |
| 10-yr return (annualized) | +8.9% | +9.0% |
| Best quarter | — | +23.4% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $5.9B | $751.7M |
| Number of holdings | 155 | 277 |
| Portfolio turnover | 49% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of SHSCX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | SHSCX | QAAGZX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 14.06% |
| Johnson & Johnson | 8.77% | 6.64% |
| Unitedhealth Group Inc | 6.10% | 5.88% |
| Merck & Company Inc | 4.94% | 4.00% |
| Gilead Sciences Inc | 4.19% | 2.79% |
| Abbvie Inc | 3.94% | 5.12% |
| Amgen Inc | 3.37% | 1.80% |
| Thermo Fisher Scientific Inc | 3.02% | 2.53% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.26% |
| Danaher Corp | 2.00% | 1.44% |
| Abbott Laboratories | 1.97% | 1.91% |
| Intuitive Surgical Inc | 1.95% | 1.89% |
| Elevance Health Inc | 1.56% | 1.54% |
| Stryker Corp | 1.15% | 1.78% |
Source: SEC Form N-PORT
SHSCX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between SHSCX and QAAGZX?
SHSCX (Blackrock Health Sciences Opportunities Portfolio) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. QAAGZX is cheaper at 0.86% vs 1.9% — a difference of $104 a year per $10,000 invested.
Which is cheaper, SHSCX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both SHSCX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.